|
Volumn 188, Issue 5, 2004, Pages 611-613
|
Living donor kidney transplantation in a Veterans Administration medical center
|
Author keywords
Kidney transplantation; Living related; Living unrelated
|
Indexed keywords
AZATHIOPRINE;
BASILIXIMAB;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ARTICLE;
FEMALE;
GOVERNMENT;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
SURVIVAL RATE;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HOSPITALS, VETERANS;
HUMANS;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
MALE;
POSTOPERATIVE COMPLICATIONS;
REGISTRIES;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 8544233509
PISSN: 00029610
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjsurg.2004.07.022 Document Type: Article |
Times cited : (7)
|
References (9)
|